mychoiceTM Implementation With Medical Oncology Patients
Launched by FOX CHASE CANCER CENTER · Jan 22, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called mychoiceTM Implementation With Medical Oncology Patients, is looking at how well a new tool called mychoiceTM works for patients with cancer. The goal is to see if this tool can help patients talk to their doctors about clinical trials as a treatment option during their cancer care. The study is currently recruiting participants and aims to understand how easy and helpful it is for patients to use this tool after their first visit with an oncology provider.
To be eligible for the trial, participants need to be at least 18 years old, speak and read English, and have been diagnosed with cancer. They should also have provided a cell phone number or email address in their medical records. If you join the study, you can expect to receive the mychoiceTM tool and share your experiences about it with the research team. This feedback will help determine how valuable the tool is for improving conversations about treatment options in oncology.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or over
- • Able to speak and read English
- • Medical Oncology patients who have had their initial visit
- • Have a cell phone number and/or an email in the electronic medical record
- • Exclusion Criteria
- • Doesn't not speak or read English
- • Patients who do not have a cancer diagnosis
About Fox Chase Cancer Center
Fox Chase Cancer Center is a leading academic research institution dedicated to advancing cancer treatment and prevention through innovative clinical trials and cutting-edge research. As a National Cancer Institute-designated Comprehensive Cancer Center, it combines a multidisciplinary approach with a commitment to patient-centered care, fostering collaboration among experts in oncology, surgery, radiation therapy, and supportive care. Fox Chase is renowned for its pioneering contributions to cancer research, translating discoveries into effective therapies and improving patient outcomes, while also prioritizing education and community outreach to enhance public awareness of cancer prevention and treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
Linda Fleisher, PhD, MPH
Principal Investigator
Fox Chase Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported